Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 516,644 | 189,487 | 333,040 | 434,883 | 531,551 |
| Depreciation Amortization | 300,770 | 148,528 | 591,035 | 435,878 | 289,878 |
| Income taxes - deferred | 60,706 | 41,372 | 273,660 | 200,056 | 56,882 |
| Accounts receivable | -288,437 | -132,292 | -81,176 | -74,622 | -101,746 |
| Accounts payable and accrued liabilities | -68,887 | -38,537 | -35,959 | -12,800 | 35,228 |
| Other Working Capital | -248,597 | -292,613 | 98,899 | 115,462 | 27,202 |
| Other Operating Activity | 478,916 | 225,359 | 592,141 | 283,391 | 85,580 |
| Operating Cash Flow | $751,115 | $141,304 | $1,771,640 | $1,382,248 | $924,575 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,241 | 12 | 29,977 | -736 | 30,369 |
| PPE Investments | 3,477,463 | -184,975 | -836,933 | -570,391 | -357,736 |
| Net Acquisitions | -65,970 | -11,274 | -183,156 | -113,526 | -89,465 |
| Purchase Of Investment | -6,715 | -4,276 | -19,177 | 19,754 | -10,241 |
| Other Investing Activity | 155 | 155 | 3,646 | 3,580 | 3,009 |
| Investing Cash Flow | $3,402,692 | $-200,358 | $-1,005,643 | $-661,319 | $-424,064 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 32,367,300 | 17,133,460 | 59,934,750 | 41,674,280 | 28,128,130 |
| Debt Repayment | -33,527,790 | -16,776,270 | -59,234,950 | -40,828,440 | -27,556,350 |
| Common Stock Issued | 2,107 | 1,517 | 13,577 | 8,803 | 3,132 |
| Common Stock Repurchased | -73,078 | N/A | -1,161,511 | -1,161,511 | -805,179 |
| Other Financing Activity | -79,092 | -33,756 | -177,220 | -116,471 | -75,642 |
| Financing Cash Flow | $-1,310,553 | $324,951 | $-625,354 | $-423,339 | $-305,909 |
| Exchange Rate Effect | -77 | -921 | -3,350 | -5,790 | -3,473 |
| Beginning Cash Position | 415,420 | 415,420 | 518,920 | 518,920 | 518,920 |
| End Cash Position | 3,682,410 | 561,434 | 415,420 | 540,155 | 480,148 |
| Net Cash Flow | $3,266,990 | $146,014 | $-103,500 | $21,235 | $-38,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | 751,115 | 141,304 | 1,771,640 | 1,382,248 | 924,575 |
| Capital Expenditure | -373,918 | -198,878 | -987,138 | -705,659 | -473,977 |
| Free Cash Flow | 377,197 | -57,574 | 784,502 | 676,589 | 450,598 |